Company news
Cipher Pharmaceuticals Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Cipher Pharmaceuticals acquires three products from Astion Pharma
February 26, 2015
Cipher Reports Financial Results for Fiscal 2014
February 25, 2015
Cipher Pharmaceuticals Announces Beteflam Patch Accepted For Review By Health Canada
February 12, 2015
Cipher Pharmaceuticals to present at BIO CEO & Investor Conference 2015
February 9, 2015
Notice of Cipher Pharmaceuticals Inc. Q4 and year-end 2014 conference call
February 3, 2015
Cipher Pharmaceuticals appoints Lynne Bulger as Vice President, Medical Affairs
January 19, 2015
Cipher Pharmaceuticals acquires assets of Melanovus Oncology Inc.
January 9, 2015
Cipher Pharmaceuticals acquires Canadian commercialization rights to novel antibacterial compound Ozenoxacin
January 7, 2015
Cipher Pharmaceuticals Inc. Announces Adoption of Advance Notice By-Law
December 18, 2014
Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2014
November 25, 2014
Cipher Pharmaceuticals to commence trading on the NASDAQ Global Market
November 20, 2014
Cipher Reports Financial Results for Q3 2014
October 29, 2014
Notice of Cipher Pharmaceuticals Inc. Q3 2014 Conference Call
October 20, 2014
Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference
September 3, 2014
Cipher reports financial results for Q2 2014
July 30, 2014
Cipher Pharmaceuticals and Ranbaxy Announce Distribution Agreement for Isotretinoin Product in Brazil
July 24, 2014
Notice of Cipher Pharmaceuticals Inc. Q2 2014 Conference Call
July 16, 2014
Cipher Pharmaceuticals appoints Shawn Patrick O'Brien as CEO
June 26, 2014
Cipher Pharmaceuticals completes distribution and supply agreement for isotretinoin product in Chile
June 18, 2014
Cipher Pharmaceuticals Inc. to present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
June 5, 2014
Cipher Pharmaceuticals Inc. Reports Voting Results from Annual General Meeting of Shareholders
May 5, 2014
Cipher reports financial results for Q1 2014
May 2, 2014
Notice of Cipher Pharmaceuticals Inc. Q1 2014 conference call and 2013 Annual General Meeting of Shareholders
April 21, 2014
Cipher appoints Thomas Wellner to Board
March 25, 2014
Cipher announces management change
March 14, 2014
Cipher reports record financial results for 2013
February 26, 2014
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2013 conference call
February 12, 2014
Cipher Appoints Gerald McDole as Chair of the Board
February 5, 2014
Cipher achieves sales milestone for Absorica
January 21, 2014
Cipher Announces Change to Board of Directors
December 30, 2013
Cipher reports record financial results for Q3 2013
October 30, 2013
Notice of Cipher Pharmaceuticals Inc. Q3 2013 Conference Call
October 22, 2013
Cipher's Partner Ranbaxy receives Paragraph IV Certification
September 19, 2013
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
September 13, 2013
Smallcappower.com Daily Investment Idea: Canadian Stocks Beating Earnings Estimates During 2Q 2013 Include Cipher Pharmaceuticals Inc, Counsel Corp and Canfor Corp
August 16, 2013
Cipher reports record financial results for Q2 2013
July 31, 2013
Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference Call
July 17, 2013
Cipher introduces Epuris(TM) (isotretinoin) capsules in Canadian market
July 2, 2013
Cipher reports record financial results for Q1 2013
May 3, 2013
Cipher Pharmaceuticals completes Latin American distribution and supply agreement for extended-release tramadol
April 29, 2013
Notice of Cipher Pharmaceuticals Inc. Q1 2013 Conference Call and 2012 Annual and Special Meeting of Shareholders
April 15, 2013
Cipher reports record financial results for 2012
March 1, 2013
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2012 Conference Call
February 21, 2013
Cipher Pharmaceuticals to present at Biotech Showcase(tm) 2013
January 3, 2013
Calls
The 5 newest of 14 calls. Every call is listed under its year.
- Cipher Pharmaceuticals (TSX:CPH) Q2 2026 Earnings Call
Aug 12, 2026
Transcript - Cipher Pharmaceuticals (TSX:CPH) Q1 2026 Earnings Call
May 8, 2026
Transcript - Cipher Pharmaceuticals (TSX:CPH) Q4 2025 Earnings Call
Mar 13, 2026
Transcript - Cipher Pharmaceuticals (TSX:CPH) Q3 2025 Earnings Call
Nov 7, 2025
Transcript - Cipher Pharmaceuticals (TSX:CPH) Q2 2025 Earnings Call
Aug 8, 2025
Transcript
Decks
- Q1 2026 Earnings Presentation
Earnings · 14 slides · May 8, 2026
- Investor Presentation (November 2025)
Investor deck · 14 slides · November 2025
- BioFinance 2005
Conference · 29 slides · Aug 18, 2005